Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRELID3BP7 is a processed pseudogene that represents a non-functional copy of a protein-coding gene. As a member of the PRELID pseudogene family, it shares sequence homology with PRELI domain-containing proteins but lacks the ability to produce functional proteins. While not a direct therapeutic target itself, pseudogenes like PRELID3BP7 contribute to the complex regulatory networks within cells and may have indirect roles in disease processes through their interactions with regulatory RNAs and proteins. The study of such pseudogenes has revealed their potential importance in cancer biology and cellular regulation, though specific therapeutic applications for PRELID3BP7 remain to be established.
Not applicable as a direct therapeutic target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELI domain containing 3B pseudogene 7 (PRELID3BP7).